Dirk Theile
18PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (18)
Sort by Publication Date:
|Mar 11, 2026
Rifabutin boosts rifampicin accumulation in THP-1-derived M2 macrophages by inhibiting P-glycoprotein efflux activity.Katharina Hamburg, Cindy Bay, Jürgen Burhenne
|Jan 09, 2026
THP-1-derived polarized macrophages differ by drug transporter transcriptomics, P-glycoprotein activity and rifampicin uptake kinetics.Katharina Hamburg, Cindy Bay, Jürgen Burhenne
|Aug 17, 2024
Perfusate Flow Rate: An Overlooked Factor in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?Dirk Theile, David Czock
|Oct 13, 2023
Rifabutin but not rifampicin can partly out-balance P-glycoprotein induction by concurrent P-glycoprotein inhibition through high affinity binding to the inhibitory site.Lottida Phondeth, Rajamanikkam Kamaraj, Julie Nilles
|Jun 07, 2023
Comprehensive in vitro analysis evaluating the variable drug-drug interaction risk of rifampicin compared to rifabutin.Julie Nilles, Johanna Weiss, Max Sauter
|Apr 20, 2023
Physiology-based pharmacokinetic modelling and experimental data suggest that rifabutin alters dolutegravir kinetics by both P-glycoprotein induction and concurrent inhibition.Dirk Theile, Julie Nilles, Andreas D Meid
Pageof 3
Frequent Collaborators
3 joint publications
Rémi Longuespée
3 joint publications
Margaux Fresnais
3 joint publications
Walter Emil Haefeli
2 joint publications
Jürgen Burhenne
2 joint publications
Johanna Weiss
1 joint publications
Lelia Wagner
1 joint publications
Juan Pablo Rigalli
1 joint publications
Johannes Ungermann
1 joint publications
Marius Breitkopf
1 joint publications
Andreas D Meid
